Certified by Founder
Lodge
AAVantgarde Bio
start up
Italy
- Milan, Lombardy
- 07/06/2023
- Series A
- $65,333,745
Delivering the next generation gene therapies
- Industry Biotechnology Research
- Website https://www.aavantgardebio.com/
- LinkedIn https://www.linkedin.com/company/aavantgarde-bio/
Related People
Natalia Misciattelli Mocenigo SoranzoFounder
United Kingdom -
Victoria, England
A well-rounded Biotech business executive with a proven track record of delivering shareholder value internationally.
Science and finance background combined with a passion for working in cutting edge technology. Creative thinker with expertise in generating and executing strategies to deliver company growth.
Experienced in building and leading teams through complex growth and transformation whilst managing multiple stakeholder groups in a fast pace evolving landscape. Strong leader skilled at building strategic relationships to drive opportunities and change in organizations.
SPARK Microsystems | $12,364,525 | (Mar 24, 2026)
Meadow Memorials | $9,000,000 | (Mar 24, 2026)
Oryon Cell Therapies | $21,000,000 | (Mar 24, 2026)
Hamilton AI | $7,500,000 | (Mar 24, 2026)
Flourish Care | $5,700,000 | (Mar 24, 2026)
Interloom | $16,500,000 | (Mar 24, 2026)
eternal.ag | $9,271,160 | (Mar 24, 2026)
EGIDE | $9,266,200 | (Mar 24, 2026)
Cleavr | $1,158,600 | (Mar 24, 2026)
JAAQ | $17,416,100 | (Mar 24, 2026)
CisLunar Industries | $2,600,000 | (Mar 24, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)